Covered recipient · General Payments record
INGRID H OLHOFFER
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$1,020.18
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $376.84 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $76.81 | 3 |
| ABBVIE INC. | $67.67 | 3 |
| Lilly USA, LLC | $59.98 | 2 |
| Regeneron Healthcare Solutions, Inc. | $46.58 | 2 |
| Amgen Inc. | $30.99 | 1 |
| GENZYME CORPORATION | $30.68 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.91 | 1 |
| Incyte Corporation | $23.16 | 1 |
| Janssen Biotech, Inc. | $16.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.25 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105151711 | CMS |
| ABBVIE INC. | $21.59 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105151713 | CMS |
| ABBVIE INC. | $25.83 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105151715 | CMS |
| Amgen Inc. | $30.99 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117343056 | CMS |
| GENZYME CORPORATION | $30.68 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139980176 | CMS |
| Incyte Corporation | $23.16 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141178288 | CMS |
| Janssen Biotech, Inc. | $16.06 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078461683 | CMS |
| Lilly USA, LLC | $29.99 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135008737 | CMS |
| Lilly USA, LLC | $29.99 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135028004 | CMS |
| Novartis Pharmaceuticals Corporation | $24.91 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087305109 | CMS |
| PFIZER INC. | $19.85 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131145261 | CMS |
| PFIZER INC. | $32.94 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131468880 | CMS |
| PFIZER INC. | $24.02 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131468876 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.21 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114127476 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.37 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114127478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.